Unicycive Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $1.60 on 04/04/24, while the lowest price for the same duration was marked at $0.20 on 08/13/24.
52-week price history of UNCY Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Unicycive Therapeutics Inc’s current trading price is -59.81% away from its 52-week high, while its distance from the 52-week low is 218.37%. The stock’s price range during the 52-week period has remained between $0.20 and $1.60. In the Healthcare sector, the company’s shares saw a trading volume of around 2.07 million for the day, which was evidently higher than the average daily volume of 1.01 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Unicycive Therapeutics Inc (UNCY) has experienced a quarterly decline of -2.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 66.75M and boasts a workforce of 14 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6143, with a change in price of +0.2281. Similarly, Unicycive Therapeutics Inc recorded 1,292,655 in trading volume during the last 100 days, posting a change of +54.96%.
Examining UNCY’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for UNCY stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
UNCY Stock Stochastic Average
Unicycive Therapeutics Inc’s raw stochastic average for the past 50 days is presently 66.81%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 79.46%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 85.90% and 86.60%, respectively.
UNCY Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -19.03%.However, over the last six months, we can see a weaker performance of 49.56%. Over the last 30 days, the price of UNCY has fallen by 4.25%. And in the last five days, it has surged by 10.69%.
